L

Lion Point Capital, LP Portfolio Analytics

Investment Analysis & Holdings Breakdown

Comprehensive portfolio analytics for Lion Point Capital, LP with $17.6M in long positions as of Q3 2025, 98% allocated to Healthcare, and 58% concentrated in top 10 positions.

Portfolio Value
$17.6M
Top 10 Concentration
58%
Top Sector
Healthcare (98%)
US Exposure
79%
Market Cap Focus
Small Cap
Countries
5

Composition Analysis

Portfolio breakdown by sector, industry, and market capitalization

Sector Allocation

Healthcare: 98.10%Healthcare
Healthcare
98.10%

Industry Breakdown

2 industries across all sectors

Biotechnology: 92.93%BiotechnologyDrug Manufacturers - Specialty & Generic: 5.18%
Biotechnology
Healthcare
92.93%
Drug Manufacturers - Specialty & Generic
Healthcare
5.18%

Filter by Sector

Select a sector to filter industries

Market Cap Distribution

Large Cap ($10B - $200B): 9.40%Large Cap ($10B - $200B)Mid Cap ($2B - $10B): 25.25%Mid Cap ($2B - $10B)Small Cap ($300M - $2B): 39.07%Small Cap ($300M - $2B)Micro Cap ($50M - $300M): 23.20%Micro Cap ($50M - $300M)Nano Cap (< $50M): 1.19%N/A (ETF or Unknown): 1.89%
Large Cap ($10B - $200B)
9.40%
Mid Cap ($2B - $10B)
25.25%
Small Cap ($300M - $2B)
39.07%
Micro Cap ($50M - $300M)
23.20%
Nano Cap (< $50M)
1.19%
N/A (ETF or Unknown)
1.89%

Portfolio Concentration

Top 10 Holdings %
58.11%
Top 20 Holdings %
91.11%
Top 50 Holdings %
100.0%
Top 100 Holdings %
100.0%

Geographic Exposure

Portfolio breakdown by country of incorporation

Domestic (US)
79.43%
International
20.57%
Countries
5
Largest Int'l Market
Canada - 7.48%
United States of America
79.43% ($14.0M)
23 holdings
Canada
7.48% ($1.3M)
1 holdings
Ireland
5.18% ($911.6K)
1 holdings
Bermuda
5.16% ($908.6K)
1 holdings
Switzerland
2.75% ($484.0K)
1 holdings

Holding Behavior

Investment patterns and position management analysis

Portfolio Stability & Commitment

Avg. Top 10
10.3 quarters
Avg. Top 20
7.4 quarters
Avg. All Positions
5.9 quarters
Median Holding Period
5 quarters
Persistence Rate
66.67%
Persistent Holdings Weight
81.81%
Persistent Positions
18
Longest Held
Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares logo
Kiniksa Pharmaceuticals International, plc Class A Ordinary SharesKNSA - 22 quarters

Position Sizing & Influence

Current Quarter

Avg. New Position
2.32%
Avg. Position Weight
3.70%
Largest Position
Mineralys Therapeutics, Inc. Common Stock logo
Mineralys Therapeutics, Inc. Common StockMLYS - 8.40%
Largest Ownership Stake
Jasper Therapeutics, Inc. Common Stock logo
Jasper Therapeutics, Inc. Common StockJSPR - 1.43%
Avg. Ownership Stake
0.22%
Ownership Stake >5%
0
Ownership Stake >1%
1

Historical (Since Q4 2015)

Avg. New Position
4.64%
Avg. Ownership Stake
3.18%
Largest Position
Ally Financial Inc. logo
Ally Financial Inc.ALLY - 72.93% (Q1 2016)
Largest Ownership Stake
Marinus Pharmaceuticals, Inc logo
Marinus Pharmaceuticals, IncMRNS - 29.57% (Q2 2020)

Portfolio Turnover

Current Quarter

Turnover Ratio
28.4%
Value Traded
$5.00M
Positions Added
7
Positions Exited
0

Historical (Since Q4 2015)

Avg. Turnover Ratio
19.7%
Avg. Positions Added
4
Avg. Positions Exited
3
Highest Turnover
50.0%
Q4 2015
Lowest Turnover
5.1%
Q4 2023

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.